This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Nutritional and Metabolic Disorders  • Nutritional and Metabolic Disorders, Other  • Dermatology  • Dermatologic Disorders  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Stefan Schanz, MD; Anja Ulmer, MD; Gerhard Fierlbeck, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

The authors report 2 cases that showed less improvement of dystrophic calcification than we described.¹ Because their patients had calcification due to dermatomyositis, the authors assume that IVIg might be a treatment option mainly for dystrophic calcification associated with vascular disease. However, we herein describe another patient with dystrophic calcification who was treated with IVIg for dermatomyositis and who was briefly mentioned in our original article.¹

A 53-year old woman with severe skin manifestations and myositis received a second-line treatment with IVIg. In addition, she had large calcium deposits in her hips and buttocks. After a few cycles of IVIg treatment, we were surprised to notice the disappearance of the calcifications. When she had received 14 cycles of the treatment, almost all of the deposits had disappeared. Therefore, we do not think the effect of IVIg therapy on calcification . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?